Free Trial

Johnson Matthey (LON:JMAT) Reaches New 1-Year High - Still a Buy?

Johnson Matthey logo with Basic Materials background

Johnson Matthey PLC (LON:JMAT - Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 1,873 ($25.44) and last traded at GBX 1,852.15 ($25.16), with a volume of 543474 shares. The stock had previously closed at GBX 1,852 ($25.16).

Johnson Matthey Stock Up 1.2%

The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. The firm has a market cap of £3.14 billion, a P/E ratio of 31.86, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The stock's 50 day simple moving average is GBX 1,633.40 and its 200 day simple moving average is GBX 1,450.75.

Johnson Matthey (LON:JMAT - Get Free Report) last released its quarterly earnings data on Thursday, May 22nd. The company reported GBX 149.20 ($2.03) EPS for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. Research analysts anticipate that Johnson Matthey PLC will post 173.4112903 EPS for the current year.

Insider Activity

In related news, insider Liam Condon purchased 30 shares of the stock in a transaction dated Wednesday, April 16th. The stock was purchased at an average price of GBX 1,200 ($16.30) per share, with a total value of £360 ($489.06). Insiders have purchased a total of 62 shares of company stock valued at $84,978 in the last quarter. 0.61% of the stock is currently owned by company insiders.

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.

Featured Stories

Should You Invest $1,000 in Johnson Matthey Right Now?

Before you consider Johnson Matthey, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.

While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines